Julian A Waksal (John O Mascarenhas, John Mascarenhas)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Acute Myeloid Leukemia

Peritoneal Dialysis

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Therapeutic advances in hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Harry Fruchtman, Zachary M Avigan, Julian A Waksal, Nicole Brennan, John O Mascarenhas
Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemia. Leukemia 38 (5) (2024)
Harry Fruchtman, Zachary M Avigan, Julian A Waksal, Nicole Brennan, John O Mascarenhas
Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemia. Leukemia 38 (5) (2024)
Pankit Vachhani, Julian A Waksal, Prithviraj Bose, Gabriela Hobbs, Abdulraheem Yacoub, Jeanne M Palmer, Aaron T Gerds, Lucia Masarova, Andrew T Kuykendall, Raajit K Rampal, Ruben Mesa, Srdan Verstovsek
Interferons in the treatment of myeloproliferative neoplasms. Therapeutic advances in hematology 15 (2024)
Harry Fruchtman, Zachary M Avigan, Julian A Waksal, Nicole Brennan, John O Mascarenhas
Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemia. Leukemia 38 (5) (2024)
Harry Fruchtman, Zachary M Avigan, Julian A Waksal, Nicole Brennan, John O Mascarenhas
Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemia. Leukemia 38 (5) (2024)
Pankit Vachhani, Julian A Waksal, Prithviraj Bose, Gabriela Hobbs, Abdulraheem Yacoub, Jeanne M Palmer, Aaron T Gerds, Lucia Masarova, Andrew T Kuykendall, Raajit K Rampal, Ruben Mesa, Srdan Verstovsek
Interferons in the treatment of myeloproliferative neoplasms. Therapeutic advances in hematology 15 (2024)
Pankit Vachhani, Julian A Waksal, Prithviraj Bose, Gabriela Hobbs, Abdulraheem Yacoub, Jeanne M Palmer, Aaron T Gerds, Lucia Masarova, Andrew T Kuykendall, Raajit K Rampal, Ruben Mesa, Srdan Verstovsek
Interferons in the treatment of myeloproliferative neoplasms. Therapeutic advances in hematology 15 (2024)
Harry Fruchtman, Zachary M Avigan, Julian A Waksal, Nicole Brennan, John O Mascarenhas
Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemia. Leukemia (2024)
Helen O Ajufo, Julian A Waksal, Julian A Waksal, Raajit K Rampal
Treating accelerated and blast phase myeloproliferative neoplasms: progress and challenges. Therapeutic advances in hematology 14 (2023)
Julian A Waksal, Claudia Bruedigam, Rami S Komrokji, Catriona H M Jamieson, John O Mascarenhas
Telomerase-Targeted Therapies in Myeloid Malignancies. Blood advances (2023)
Amanda C Przespolewski, Aaron D Goldberg, Chetasi Talati, Salman Fazal, Pankit Vachhani, Srinivasa Reddy Sanikommu, Swapna Thota, Julian A Waksal, Brian John Ball, Christopher A Famulare, Maximilian Stahl, Jeffrey Baron, Elizabeth A Griffiths, James E Thompson, Kendra L Sweet, Eunice S Wang
Safety and efficacy of CPX-351 in younger patients (< 60 years) with secondary acute myeloid leukemia. Blood (2022)
Amanda C Przespolewski, Aaron D Goldberg, Chetasi Talati, Salman Fazal, Pankit Vachhani, Srinivasa Reddy Sanikommu, Swapna Thota, Julian A Waksal, Brian John Ball, Christopher A Famulare, Maximilian Stahl, Jeffrey Baron, Elizabeth A Griffiths, James E Thompson, Kendra L Sweet, Eunice S Wang
Safety and efficacy of CPX-351 in younger patients (< 60 years) with secondary acute myeloid leukemia. Blood (2022)